Lopresti Angelo P sold $110K of IPGP

Lopresti Angelo P (SVP, Secretary & Gen Counsel) sold 1,000 shares of IPG PHOTONICS CORP (IPGP) at $110.33 ($0.11M total) on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lopresti Angelo P
Published Jul 1, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IPGP
Neutral
high confidence
Mentioned
$IPGP
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IPGPNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings by a senior legal officer, under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no accompanying fundamental catalyst in the text.

03

What to watch

The disclosure states the sale was under a pre-arranged 10b5-1 plan, which generally implies reduced informational content versus discretionary selling.

Relevance 3/10Novelty 2/10Timing: filed 2026-07-01, transaction dated 2026-06-29

Background

The article is a SEC Form 4 insider transaction disclosure for IPG Photonics, reported via EDGAR.

Company-level read

Ticker impact

$IPGPNeutralHigh confidence
Context

IPG Photonics disclosed an open-market sale by SVP, Secretary and Gen Counsel Angelo P. Lopresti of 1,000 shares at $110.33 on 2026-06-29.

Expected impact

Likely minimal price impact; any effect is more about sentiment than new company information.

Evidence & confidence

Form 4 provides transaction details but does not indicate new operational, financial, or regulatory developments. The filing explicitly notes a pre-arranged 10b5-1 plan, which typically reduces interpretive weight.

Market effects

No clear sector read-through; insider sale is company-specific and not tied to guidance or industry catalysts.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification or tax planning, so the market may overreact if traders treat it as a bearish fundamental signal.

Key entities

  • IPG Photonics Corp

    Company that filed the Form 4 insider transaction disclosure.

  • Angelo P. Lopresti

    SVP, Secretary and Gen Counsel who sold 1,000 shares at $110.33 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IPGPMed

Why IPG Photonics (IPGP) shares are falling today

IPG Photonics (IPGP) shares fell 9.8% after Democratic senators called for slowing AI data center development, impacting chipmakers. Micron paused a $4.5B plant in Taiwan due to labor disputes. IPGP is down 15.9% YTD, trading 59.2% below its 52-week high. Rising Treasury yields also weigh on semiconductor stocks.

$IPGPMed

IPG Photonics Corp (IPGP) (Q3 2026) Earnings Call Highlights: Fourth Straight Quarter

IPG Photonics (IPGP) expects Q4 revenue of $265-$295M, with adjusted gross margin declining to 37-40% due to lower tariff refunds. European sales fell 1% YoY, while defense revenue is lumpy. CEO Dr. Mark Gitin sees long-term growth in battery, semiconductor, and medical sectors. CFO Timothy Mammen notes cost pressures but expects gross margin improvements in 2027. Medical and semiconductor are key growth drivers.

$IPGPLow

IPG Photonics (IPGP) Beat Q3 Estimates, Is It Still Below Fair Value?

IPG Photonics (IPGP) reported Q3 2026 sales of $287.5M and net income of $20.27M, beating estimates. Despite this, shares fell 11.46% in 30 days and 11.40% over 1 year. The stock closed at $74.42, with some analysts valuing it 40% below fair value at $124.14, citing growth opportunities. However, its P/E ratio of 114.9x raises valuation concerns compared to industry peers.

MedAI 8/10

IPG Photonics Corporation Q3 2026 Earnings Call Summary

IPG Photonics reported Q3 2026 revenue growth of 15%, driven by industrial and advanced solutions. Advanced Solutions revenue surged 33% YoY, led by semiconductor and defense applications. The company expects medical business growth to double in 2-3 years post-Lumibird Medical acquisition. Q4 guidance accounts for moderation in China's battery capacity additions. The company maintains a strong balance sheet with $926M in cash and no debt.

$IPGPMedAI 8/10

IPG Photonics (IPGP) Q3 2026 Earnings Call Transcript

IPG Photonics (IPGP) reported Q3 2026 earnings, with revenue up 15% YoY to $288M. Industrial Solutions revenue grew 12% YoY, driven by welding and additive manufacturing. Advanced Solutions revenue increased 33% YoY, with strong growth in semiconductor and defense applications. The company announced the acquisition of Lumibird Medical, expected to close in Q4, expanding its medical laser platform. IPGP plans to host an Investor Day on March 2, 2027.